Significantly Reduced the Need for SCS Use or Sino‑Nasal Surgery vs Placebo in a Prespecified Multiplicity-Controlled Pooled Analysis of SINUS‑24 and SINUS‑521,2,a
TIME TO FIRST SCS USE OR CRSwNP SURGERY DURING THE TREATMENT PERIOD
SCS Use at Week 52
- 75% REDUCTION IN SCS COURSES PER YEAR
(RR: 0.25 [95% CI: 0.17, 0.37])1
surgery at week 52
aIndividually, SCS reduction and need for sino-nasal surgery were not multiplicity-adjusted endpoints.3
HR, hazard ratio; RR, risk ratio.